Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Фільтри

(Clear all)

Improving quality of life of Parkinson’s disease patients by Quantitative Cognitive Testing

ParSyncR

Parkinson’s disease is dominated by motor symptoms such as tremor, bradykinesia and postural instability. However, over 90% of all patients develop cognitive impairment including deterioration of learning, memory and decision making. Current treatments focus on motor symptoms and offer at best moderate improvement of cognitive functions...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

Improving Translational Research Potential at the Institute of Biomedicine of Seville

ITRIBIS

The ITRIBIS project is envisaged to improve research at the Institute of Biomedicine of Seville (IBiS) and to help this center to become a reference of biomedical translational research applied to prevalent diseases in Southern Europe. It also aims to boosting the transfer of results to the clinical setting and to the local biotechnological...

Funding Programme
Start Date
End Date
Total Funding
€ 4 709 745
European Countries Involved

In search for endothelial mechanisms of TPO-induced neuroprotection

TONEURENDO

Ageing is recognized as one of the greatest social and economical challenges of the 21century for European societies. With, Vascular Cognitive Impairment (VCI) being one of the leading causes of age-related cognitive impairment and one of the major causes of disability in the elderly. Although, the concept of VCI was introduced in 1993, current...

Funding Programme
Start Date
End Date
Total Funding
€ 146 462
European Countries Involved

In silico modeling of multi-domain proteins in biological condensates

MMultiDP

Neurodegenerative disorders are one of the leading causes of disabilities and death in elderly populations worldwide. To this date, no established treatment can either prevent or slow down the progression of these diseases. Their occurrences and progression are strongly correlated with insoluble biological condensates composed of nucleic acids and...

Funding Programme
Start Date
End Date
Total Funding
€ 230 774
European Countries Involved

IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS

In-Cytes

MaxWell Biosystems AG (MxW) is a Swiss public limited company (AG) who developed electrophysiological platforms (hardware-software-bioassays) for basic research and drug testing on nerve cells. MxW’s aim is to develop In-Cytes, a radically innovative electrophysiology platform to assess neural connectivity for preclinical drug discovery for brain...

Funding Programme
Start Date
End Date
Total Funding
€ 135 500
European Countries Involved

In-Touch: Implementation of a person-centered palliative care iNtervention To imprOve comfort, QUality of Life and social engagement of people with advanced dementia in Care Homes

In-Touch

Challenge. Caring for the increasing numbers of people across Europe with advanced dementia and palliative care needs who live in care homes is difficult and demanding. People with advanced dementia can be immobile, non-verbal and unable to take part in day-to-day activities. They can be unsettled or agitated, with low quality-of-life and elevated...

Funding Programme
Start Date
End Date
Total Funding
€ 5 723 637

INdependent LIving support Functions for the Elderly

IN LIFE

The number of elderly living with cognitive impairment is growing rapidly due to increasing life expectancy. The percentage of those who live alone depends upon the condition (i.e. roughly 30% of those diagnosed with dementia) but the majority would like to live in their own home or with family, provided that it is safe, comfortable, and cost...

Funding Programme
Start Date
End Date
Total Funding
€ 3 761 729
European Countries Involved

Inflammation and AD: modulating microglia function focussing on TREM2 and CD33

PHAGO

Alzheimer’s disease (AD) is an age-related chronic neurodegenerative disease with four main pathological changes in the brain: amyloid plaques, fibrillary tau tangles, inflammation and neuronal loss. Phagocytes around amyloid plaques in late onset AD (LOAD) may be neurotoxic but have limited motility and phagocytic activity, suggesting a...

Funding Programme
Start Date
End Date
Total Funding
€ 18 088 176

Infrared nanospectroscopy to understand and combat Alzheimer's disease

nanoIR4AD

Neurodegenerative diseases are a ticking time-bomb for health care systems because they are care-intensive and will soon become much more wide-spread due to increased life expectancy. Their most common form is Alzheimer's disease (AD), in which the amyloid-ß (Aß) peptide aggregates to amyloid fibers that accumulate in plaques in the human brain. We...

Funding Programme
Start Date
End Date
Total Funding
€ 206 887
European Countries Involved

Infrastructure-based EGNOS/Galileo receiver for personal mobility

IEGLO

The main goal of the proposed project IEGLO is the development of a handheld tracking device for elderly or Alzheimer disease people. At present, in Europe approximately 4.000.000 people are Alzheimer disease-ridden. Especially this people get very often in situations where they are un-oriented. They need mentoring by either their family members or...

Funding Programme
Start Date
End Date
Total Funding
€ 387 327
European Countries Involved

Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases

IMPRiND

Assemblies of tau and α-synuclein were shown to spread along interconnected neuronal networks suggesting broadly relevant therapeutic directions for Alzheimer’s and Parkinson’s disease. This requires a pre-clinical stage of development that has yet to be met. The scale of neurodegenerative disease burden in Europe calls for an unprecedented...

Funding Programme
Start Date
End Date
Total Funding
€ 11 363 398
European Countries Involved

Initial Training Network for Neurogical disorders orchestrated by cytoKines

NEUROKINE

Neuroinflammatory disease, in particular multiple sclerosis affects more than 700.000 people within Europe alone. European countries are at the forefront of neuroimmunological research and students in medicine and biology are greatly attracted by the field. Neuroimmunology research further impacts our understanding of the ethiopathology of other...

Funding Programme
Start Date
End Date
Total Funding
€ 3 536 796
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).